Merck (NYSE:MRK) reported positive Phase 3 results for tulisokibart, an anti-TL1A monoclonal antibody in moderate-to-severe ...

Zydus and Apollo Hospitals collaborate to enhance access to a multi-cancer blood test for early detection in India.

Unlike conventional screening methods that typically target a single cancer, Shield MCD is designed to detect signals ...

Zydus Lifesciences and Apollo Hospitals are rolling out Shield MCD in India for eligible adults aged 45 and above. The launch ...

Zydus signs MoU with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection test in India: Our Bureau, Mumbai Saturday, July 4, 2026, 11:45 Hrs [IST] Zydus Lifesci ...

VCYT's 117% stock surge is driven by durable growth plans, Afirma demand, TrueMRD progress, international IVD efforts and a ...

Prostate health awareness helps men identify early signs, understand risks, and navigate PSA tests and screening with trusted ...

WHEN Chloe Venton, 15, began waking up in the middle of the night screaming in agony, her mum Joanne knew something was seriously wrong. The teen, from Swindon, began sweating excessively and ...

Zydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through an agreement with Guardant Health. This innovative blood test ...

Men often learn to live with discomfort. A little back pain, getting up twice at night to use the washroom, or a weak urine ...

June 2026 Enhertu approved in the EU as first tumour agnostic HER2-directed therapy and antibody drug conjugate for patients with previously treated HER2-positive metastatic solid tumours Based on ...